BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer

1M ago

BYSI

PremiumCompany Announcements

BeyondSpring Announces Executive Leadership Change

1M ago

BYSI

PremiumPress Releases

BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K

3M ago

BYSI

PremiumPress Releases

BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements

4M ago

BYSI

$BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors$

PremiumPress Releases

BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors

6M ago

BYSI

PremiumPress Releases

SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degradation Think Tank” Symposium

6M ago

BYSI

PremiumPress Releases

SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors

6M ago

BYSI

More BYSI News >

BYSI News on the Web

2024-03-25

BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer

Yahoo Finance

Bullish

2024-03-18

BeyondSpring Announces Executive Leadership Change

TipRanks News

Neutral

2024-03-07

Beyondspring Inc (BYSI) has gained 125.56% in a Week, Should You Buy?

Investors Observer

Neutral

2024-03-06

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

InvestorPlace

Neutral

2024-03-06

Retail investors invested in BeyondSpring Inc. up 125% last week, insiders too were rewarded

Yahoo Finance

Neutral

2024-03-06

Should You Hold Beyondspring Inc (BYSI) Stock Wednesday Morning?

Investors Observer

Neutral

2024-03-06

Beyondspring Inc (BYSI) Down 13.45% in Premarket Trading

Investors Observer

Neutral

2024-03-05

U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.04%

Investing.com

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BYSI’s Media Buzz Sentiment?

Currently, no data Available

What is BYSI’s weekly average amount of articles?

Currently, no data Available

What is BYSI’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

IMVTImmunovant

RVVRevive Therapeutics

NVSNovartis

ISRGIntuitive Surgical

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing